Medicaments
AssigneeBurroughs Wellcome Co.
InventorsVictoria S. Latter, Winston E. Gutteridge, Alan T. Hudson
Life of this patent
Estimating the term…
Abstract
A method for treating or preventing a Pneumocystis carinii infection in a mammal by administering a certain naphthoquinone compound or physiologically acceptable salts thereof.
Claims2
A method of treating malaria in a mammal comprising administering to said mammal an effective antimalarial amount of a compound 2-[trans-4-(4-chlorophenyl)cyclohexyl]-1,3,4triacetoxynaphthalene.
A pharmaceutical formulation in a form for nasal administration or pulmonary administration comprising an effective antimalaria amount of the compound 2-[trans-4-(4-chlorophenyl)cyclohexyl]-1,3,4triacetoxynaphthalene and a pharmaceutically acceptable carrier therefor.
Dependencies are inferred from the claim text.